We performed a retrospective review of patients undergoing two-stage brachiobasilic arteriovenous fistula construction at an urban academic medical center between 2012 and 2017. The second stage consisted of either tunneling the basilic vein and reanastomosis to the brachial artery, that is, "transposition," or "superficialization," which mobilized the basilic vein into the anterolateral subcutaneous plane through creation of a flap. Operative time, postoperative morbidity, access maturation, primary patency, and need for subsequent interventions were compared.
Influence of Heel Ulceration on Limb Salvage After Open and Endovascular Intervention for Limb-Threatening Critical Ischemia
Tracy J. Cheun, Mark G. Davies, MD, PhD, MBA. University of Texas Health Sciences Center-San Antonio, San Antonio, Tex
Objective: Infrapopliteal disease is documented in 50% of patients presenting with tissue loss. The implications of heel ulceration on index limb outcomes is still unclear. The aim of this study was to impact the outcomes of heel ulceration after endovascular and open intervention for limb-threatening critical ischemia Methods: A database of patients undergoing lower extremity open and endovascular interventions between 2001 and 2017 was retrospectively queried. We identified 608 patients with isolated infrapopliteal disease and heel ulceration. Heel ulceration was further stratified as less than 5 cm, 5 to 10 cm, and greater than 10 cm in diameter. An intention-to-treat analysis by patient was performed. Amputation-free survival (survival without major amputation) and freedom from major adverse limb events (above ankle amputation of the index limb) or major reintervention (new bypass graft, jump/interposition graft revision) were evaluated.
Results: There were 384 patients (58% male; average age, 65 years; 2898 vessels) who underwent endovascular tibial intervention and 124 patients (45% male; average age, 59 years) underwent superficial femoral artery or popliteal tibial bypass for limb-threatening critical ischemia (Table) . There was no difference in 30-day outcomes (Table) . Outcomes of amputationfree survival and freedom from major adverse limb event were superior in the open group. Patients with heel ulcers of less than 5 cm and 5 to 10 cm had similar outcomes. Heel ulcers greater than 10 cm diameter were associated with worse 30-day and 5-year outcomes (Table) . The presence of end-stage renal disease, osteomyelitis, and uncontrolled diabetes (glycosylated hemoglobin of >10) were associated with poor 30-day and 5-year outcomes. The combination of one or more of these variables with a heel ulcer greater than 10 cm in diameter was associated with a higher 30-day amputation rate (50% endo vs 45% open; P < .02).
Conclusions: Heel ulceration of greater than 10 cm is associated with early major adverse limb event and early amputation in both open and endovascular interventions. The presence of end-stage renal disease, osteomyelitis, and uncontrolled diabetes (glycosylated hemoglobin of >10) in combination with a large heel ulcer is predictive of early major amputation. Objective: Controlling lipids, in particular cholesterol and low-density lipoprotein cholesterol, has been identified as a key intervention to prevent adverse systemic events in patients with a high atherosclerotic burden and claudication. It is unclear if goal-directed therapy of to achieve a decrease in cholesterol (<200 mg/dL) and in low-density lipoprotein (<100 mg/dL) will influence outcomes. The aim of study was to determine the incidence and effectiveness of statin therapy on patient and procedural outcomes after SFA interventions for claudication.
Methods: A database of patients with claudication undergoing open and endovascular intervention for TransAtlantic Inter-Society Consensus II C and D femoropopliteal lesions between 2001 and 2017 was retrospectively queried. All patients were on statins at the time of the procedure. Patients were subdivided into those based on serum cholesterol and low-density lipoprotein goals: neither goal met (no effect), one of two goals met (partial), or both goals met (full). Kaplan-Meier survival analyses were performed to assess time-dependent outcomes. Factor analyses were performed using a Cox proportional hazard model for time-dependent variables.
Results: There were 1973 patients (68% male; average age, 67 years) who underwent Open and endovascular treatment for symptomatic superficial femoral artery disease. Only 52% were on statins before the procedure. Both partial and full efficacy influenced 30-day outcomes and was associated with improved freedom from major adverse limb events and amputation-free survival at 5 years (Table) .
Conclusions: Partial or fully effective goal directed statin therapy has a significant effect on 30-day and long term outcomes in patients presenting with claudication and advanced femoropopliteal disease.
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Operative Time Affects Outcomes After Lower Extremity Endovascular Revascularization
Ian Schleider, DO, Vjay Kumar Soundarapandian, PhD, Sayed Rizvii, MD, Alan Dietzek, MD. Danbury Hospital, Danbury, Conn Objectives: Longer operative times for infrainguinal revascularization have been associated with higher perioperative complication rates particularly with respect to surgical site infections and extended durations of stay. We sought to determine if prolonged procedure times after minimally invasive, endovascular interventions were also associated with increased morbidity and or mortality.
Methods: The National Surgical Quality Improvement Program 2016 Lower Extremity Target database was used. A total of 2016 patients were found suitable for review. We compared two groups: group A, those with operative times of 0 to 110 minutes, and group B, those with operative times of greater than 110 minutes. Fisher's exact test was used to calculate significance for each variable between the two groups.
Results: Prolonged operative times (>110 minutes) for endovascular procedures are associated with increased morbidity but not mortality. Higher amputation rates were also associated with prolonged operative times. This finding may be attributed to differences in indications for endovascular intervention, which were more often critical limb ischemia requiring more complex procedures.
Conclusions: Surgeons should bear in mind the greater risks for complications associated with lengthy endovascular procedures. Objectives: To identify candidates undergoing elective endovascular aneurysm repair (EVAR) of asymptomatic infrarenal abdominal aortic aneurysm who are eligible for early (#6 hours) hospital discharge or to have EVAR performed in free-standing ambulatory surgery centers.
Methods: Medical records of all elective EVAR performed at a university medical center over 5 years were reviewed for demographics, comorbidities, operative findings, postoperative care, morbidity, and mortality.
Results: There were 272 elective EVARs; patients had a mean age of 74 years (range, 52-94 years), 75% were male; and 93% were American Society of Anesthesiologists class 3 or higher. General anesthetic was used in 84%; the median operative time 152 minutes (range, 70-609 minutes). There were 25 operative major adverse events (MAE) in 21 patients (7.7%), namely, bleeding (5.9%), thrombosis (1.8%), and arterial injury (1.8%). Percutaneous EVAR was attempted in 260 patients (96%) and was successful in 238 (88%). Failed percutaneous EVAR was associated with operative MAE (P < .001). Postoperative MAE (8.8%) occurring from less than 1 hour to 7 days after the procedures included myocardial infarction (1.1%), thrombosis/reoperation (1.1%), congestive heart failure (1.5%), bleeding (0.07%), chronic obstructive pulmonary disease exacerbation (0.036%), cholecystitis (0.36%), ischemic bowel (0.36%), intensive care admission for respiratory treatment (1.5%), arrhythmia (1.1%), and preoperative comorbidity monitoring (0.7%). Combined operative/postoperative MAE was 43 (15.8%); 17 (6%) required intensive care admissiond88% directly from the operating room/post anesthesia care unit. Other AE included nausea (17%), blood pressure alteration (15%), and urinary retention (13%). Routine services included intravenous hydration, urinary catheterization, and supplemental oxygen. Other AE/need for nonroutine services occurred in 131 (48%): 79 (29%) developed/required treatment 6 hours or more postoperatively, 22 (8%) treated/resolved in 6 hours or less, and 30 (11%) were monitored only. Thirty-six percent had no complications and required routine care only. Failed percutaneous EVAR (3.4; 1.6-7.3; P ¼ .002) and aortic cuff (0.23; 0.07-0.75; P ¼ .015) were independent predictors of MAE or AE occurring/requiring treatment 6 or more hours postoperatively, but had poor sensitivity 47% and a positive predictive value of 65%. However, 91% could have been detected at 6 hours or sooner. Two MAE (0.07%; congestive heart failure at 24 hours, thrombosis/ reoperation at 15 hours) would have occurred after discharged; 9 (3%) AE/ treatment (nausea, sliding scale insulin) would have gone undetected.
Conclusions: More than one-half of all EVAR are ready for discharge within 6 hours postoperatively. Ambulatory admission provides easy inpatient transition for those requiring continued care. Failed percutaneous EVAR and aortic cuffs are independent predictors of MAE or AE occurring/requiring treatment for 6 or more hours. Although sensitivity is insufficient to advocate EVAR in free-standing ambulatory surgical units at this time, percutaneous EVAR and aortic IFUs may be key parameters to enable future free-standing ambulatory surgical units use.
